Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07426718
Recruiting
A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.
Not applicable · United Kingdom · 1 site
Registry update: 8 May 2026
NCT07450859
Recruiting
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 2 · South Korea, United States · 8 sites
Registry update: 18 Sept 2026
NCT07430943
Recruiting
Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation
Not applicable · Switzerland · 1 site
Registry update: 12 Mar 2026
2025-521408-24-00
Recruiting
Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease
Phase 3 · Poland · 2 sites
Registry update: 4 Nov 2026
NCT07259213
Recruiting
A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Phase 1/2 · Australia · 2 sites
Registry update: 1 Apr 2026
NCT07733583
Recruiting
Pelvic Floor Physical Therapy and Exercise for Women With Endometriosis and Chronic Pelvic Pain
Not applicable · Brazil · 1 site
Registry update: 29 Jul 2026
NCT07479732
Recruiting
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2 · China · 1 site
Registry update: 18 Mar 2026
NCT07438496
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Phase 3 · Argentina, Australia, Bulgaria, Brazil, Switzerland, China, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Georgia, Greece, Hungary, Israel, Italy, Japan, South Korea, Mexico, Malaysia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Thailand, Taiwan, United States, South Africa · 273 sites
Registry update: 3 Nov 2026
NCT07085728
Recruiting
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
Phase 2 · United States · 1 site
Registry update: 14 Sept 2026
NCT07445048
Recruiting
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Phase 3 · China · 1 site
Registry update: 17 Apr 2026
NCT06810635
Recruiting
Polyphenol Metabotypes in People With Diabetes Type 2
Not applicable · Belgium · 2 sites
Registry update: 23 Mar 2026
NCT07291297
Recruiting
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 · United States · 2 sites
Registry update: 23 Jul 2026
NCT07541469
Recruiting
Rezdiffra Pregnancy and Lactation Registry
Not applicable · United States · 1 site
Registry update: 21 Apr 2026
NCT07376772
Recruiting
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Not applicable · United States · 2 sites
Registry update: 3 Nov 2026
NCT07332013
Recruiting
Urinary Titin Biomarker in DMD
Not applicable · United States · 1 site
Registry update: 8 Apr 2026
2025-520790-39-00
Recruiting
CLonE-specific CAR T-Cell therapy in relapsed or refractory AL amyloidosis - a single-center Phase I trial (CLEAR AL)
Phase 1 · Germany · 1 site
Registry update: 25 Nov 2025
NCT05544968
Recruiting
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Phase 1 · United States · 1 site
Registry update: 3 Apr 2026
NCT07221838
Recruiting
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Phase 4 · Germany, Italy, Japan, United States · 11 sites
Registry update: 9 Apr 2026
Conflicting statuses (not updated in the registry for 7 months)
NCT07369076
Recruiting
A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
Phase 1/2 · Australia, Canada, Netherlands, Poland · 12 sites
Registry update: 17 Sept 2026
NCT07245992
Recruiting
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Phase 1 · Italy · 2 sites
Registry update: 14 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.